Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organophosphorus Chemistry. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102070669B discloses efficient chiral phosphamide ligands enabling high enantioselectivity in cyanosilylation. A reliable partner for cost-effective asymmetric manufacturing.
Patent CN115490730B reveals a high-yield method for chiral BIDIME selenium/sulfur ligands, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101885742B discloses a novel chiral bisphosphorodiamidate catalyst enabling high enantioselectivity in nitrile silicification, offering robust supply chain solutions.
Novel chiral phosphine amide ester catalyst enables high enantioselectivity in Henry reactions, offering scalable solutions for pharmaceutical intermediates.
Patent CN101962391B discloses a novel chiral phosphine catalyst offering high enantioselectivity for nitrile cyanosilylation, ensuring reliable supply chain solutions.
Novel preparation of cis-2-(diphenylphosphino)-1-cyclohexanecarboxylic acid via asymmetric addition. Enhances catalytic efficiency and reduces manufacturing costs for high-purity intermediates.
Patent CN102933589A details high-yield asymmetric Strecker reactions using novel N-phosphonimides, offering >99% ee for pharmaceutical intermediate manufacturing.
Patent CN115490730A reveals a novel synthesis for chiral BIDIME Se/S ligands using modified diatomite purification, offering high yields and scalable production for pharmaceutical intermediates.
Patent CN107445989B discloses novel indole-based phosphine ligands offering high catalytic activity for C-S bond formation, ensuring cost-effective pharmaceutical intermediate manufacturing.
Novel biaryl-based ligand enables high-yield palladium-catalyzed asymmetric allylic substitution with exceptional enantioselectivity and simplified synthesis.
Novel indole-based phosphine ligands enable efficient C-S bond formation with high yields, offering cost-effective solutions for pharmaceutical manufacturing.
Struggling with low enantioselectivity in asymmetric cyclizations? New axial chiral oxindole phosphine catalysts offer 95% ee and mild conditions. Find reliable suppliers for complex molecule synthesis.